Mohamed L. Sorror

18.0k total citations · 5 hit papers
160 papers, 10.9k citations indexed

About

Mohamed L. Sorror is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, Mohamed L. Sorror has authored 160 papers receiving a total of 10.9k indexed citations (citations by other indexed papers that have themselves been cited), including 133 papers in Hematology, 56 papers in Public Health, Environmental and Occupational Health and 40 papers in Genetics. Recurrent topics in Mohamed L. Sorror's work include Hematopoietic Stem Cell Transplantation (106 papers), Acute Myeloid Leukemia Research (61 papers) and Acute Lymphoblastic Leukemia research (53 papers). Mohamed L. Sorror is often cited by papers focused on Hematopoietic Stem Cell Transplantation (106 papers), Acute Myeloid Leukemia Research (61 papers) and Acute Lymphoblastic Leukemia research (53 papers). Mohamed L. Sorror collaborates with scholars based in United States, South Africa and Germany. Mohamed L. Sorror's co-authors include Brenda M. Sandmaier, Rainer Storb, David G. Maloney, Barry E. Storer, Michael B. Maris, Frédéric Baron, Frederick R. Appelbaum, Ted Gooley, H. Joachim Deeg and Paul J. Martin and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Mohamed L. Sorror

155 papers receiving 10.8k citations

Hit Papers

Hematopoietic cell transp... 2005 2026 2012 2019 2005 2010 2011 2016 2016 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
    2005 2.0k citations Mohamed L. Sorror, Michael B. Maris et al. Blood profile →
  2. Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
    2010 1.0k citations Ted Gooley, Mohamed L. Sorror et al. profile →
  3. Long-Term Survival and Late Deaths After Allogeneic Hematopoietic Cell Transplantation
    2011 443 citations Ruta Brazauskas, David A. Jacobsohn et al. Journal of Clinical Oncology profile →
  4. Cytomegalovirus viral load and mortality after haemopoietic stem cell transplantation in the era of pre-emptive therapy: a retrospective cohort study
    2016 295 citations Wendy M. Leisenring, Brenda M. Sandmaier et al. profile →
  5. Cord-Blood Transplantation in Patients with Minimal Residual Disease
    2016 284 citations Ted Gooley, Ann E. Woolfrey et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohamed L. Sorror United States 46 8.4k 2.9k 2.8k 2.1k 1.9k 160 10.9k
Michael B. Maris United States 50 7.8k 0.9× 2.3k 0.8× 2.8k 1.0× 1.6k 0.8× 2.5k 1.3× 173 11.0k
Myriam Labopin France 63 12.3k 1.5× 4.8k 1.6× 3.6k 1.3× 2.0k 1.0× 3.1k 1.6× 510 15.2k
Karen K. Ballen United States 45 5.8k 0.7× 1.8k 0.6× 2.1k 0.7× 1.9k 0.9× 1.9k 1.0× 234 8.1k
Vincent T. Ho United States 65 10.4k 1.2× 2.3k 0.8× 3.4k 1.2× 2.1k 1.0× 5.8k 3.0× 323 14.9k
Bipin N. Savani United States 51 5.9k 0.7× 1.9k 0.7× 3.0k 1.0× 1.0k 0.5× 2.7k 1.4× 365 9.0k
Mauricette Michallet France 50 6.9k 0.8× 1.9k 0.6× 2.6k 0.9× 2.2k 1.1× 1.8k 0.9× 311 10.0k
Jean E. Sanders United States 66 11.0k 1.3× 3.5k 1.2× 3.7k 1.3× 2.5k 1.2× 3.3k 1.7× 191 15.4k
Tapani Ruutu Finland 51 6.8k 0.8× 1.8k 0.6× 2.1k 0.7× 2.3k 1.1× 1.5k 0.8× 221 10.2k
Didier Blaise France 60 12.1k 1.4× 3.7k 1.3× 5.0k 1.7× 2.1k 1.0× 5.1k 2.7× 652 16.5k
Koen van Besien United States 57 6.9k 0.8× 1.6k 0.6× 4.4k 1.5× 2.6k 1.3× 3.2k 1.7× 354 12.0k

Countries citing papers authored by Mohamed L. Sorror

Since Specialization
Citations

This map shows the geographic impact of Mohamed L. Sorror's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohamed L. Sorror with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohamed L. Sorror more than expected).

Fields of papers citing papers by Mohamed L. Sorror

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohamed L. Sorror. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohamed L. Sorror. The network helps show where Mohamed L. Sorror may publish in the future.

Co-authorship network of co-authors of Mohamed L. Sorror

This figure shows the co-authorship network connecting the top 25 collaborators of Mohamed L. Sorror. A scholar is included among the top collaborators of Mohamed L. Sorror based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohamed L. Sorror. Mohamed L. Sorror is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Othus, Megan, Harry P. Erba, Guillermo Garcia‐Manero, et al.. (2024). Association between class III obesity and overall survival in previously untreated younger patients with acute myeloid leukemia enrolled on SWOG S1203. Leukemia. 38(7). 1488–1493.
3.
Smith, Michael A., Rachel Phelan, Ruta Brazauskas, et al.. (2024). Pulmonary hypertension in the intensive care unit after pediatric allogeneic hematopoietic stem cell transplant: incidence, risk factors, and outcomes. Frontiers in Oncology. 14. 1415984–1415984. 1 indexed citations
4.
Jones, Salene M. W., et al.. (2024). Addressing financial hardship in malignant hematology and hematopoietic cell transplant: a team approach. Blood Advances. 8(19). 5146–5155. 2 indexed citations
5.
Kordelas, Lambros, Tobias Terzer, Ted Gooley, et al.. (2023). EASIX-1year and late mortality after allogeneic stem cell transplantation. Blood Advances. 7(18). 5374–5381. 15 indexed citations
6.
Abou‐Ismail, Mouhamed Yazan, Raphael Fraser, Leland Metheny, et al.. (2022). Does recipient body mass index inform donor selection for allogeneic haematopoietic cell transplantation?. British Journal of Haematology. 197(3). 326–338. 1 indexed citations
7.
Othus, Megan, Mohamed L. Sorror, Anna B. Halpern, et al.. (2022). Effect of ECOG performance status on outcomes in patients with acute myeloid leukemia and other high-grade myeloid neoplasms. Leukemia. 37(1). 231–234. 4 indexed citations
8.
Yeh, Albert C., Paul V. O’Donnell, Gary Schoch, et al.. (2021). Long-term survival with mixed chimerism in patients with AML and MDS transplanted after conditioning with targeted busulfan, fludarabine, and thymoglobulin. Bone Marrow Transplantation. 57(2). 198–206. 4 indexed citations
9.
Sorror, Mohamed L., Megan Othus, Jennifer E. Nyland, et al.. (2020). Regimen‐intensity per count‐recovery and hospitalization index: A new tool to assign regimen intensity for AML. Cancer Medicine. 9(18). 6515–6523. 1 indexed citations
10.
McDermott, Cara L., Ruth A. Engelberg, James Sibley, Mohamed L. Sorror, & J. Randall Curtis. (2020). The Association between Chronic Conditions, End-of-Life Health Care Use, and Documentation of Advance Care Planning among Patients with Cancer. Journal of Palliative Medicine. 23(10). 1335–1341. 19 indexed citations
11.
Luft, Thomas, Axel Benner, Tobias Terzer, et al.. (2019). EASIX and mortality after allogeneic stem cell transplantation. Bone Marrow Transplantation. 55(3). 553–561. 89 indexed citations
12.
Thakar, Monica S., Larisa Broglie, Brent R. Logan, et al.. (2018). The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases. Blood. 133(7). 754–762. 35 indexed citations
13.
Eissa, Hesham, Ted Gooley, Mohamed L. Sorror, et al.. (2010). Allogeneic Hematopoietic Cell Transplantation for Chronic Myelomonocytic Leukemia: Relapse-Free Survival Is Determined by Karyotype and Comorbidities. Biology of Blood and Marrow Transplantation. 17(6). 908–915. 81 indexed citations
14.
Sorror, Mohamed L. & Rainer Storb. (2010). ROLE OF COMORBIDITIES IN OPTIMIZING DECISION-MAKING FOR ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION. Mediterranean Journal of Hematology and Infectious Diseases. 2(2). e2010015–e2010015. 1 indexed citations
15.
Rotta, Marcello, Barry E. Storer, Firoozeh Sahebi, et al.. (2008). Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting. Blood. 113(14). 3383–3391. 71 indexed citations
16.
Sorror, Mohamed L., Barry E. Storer, Brenda M. Sandmaier, et al.. (2008). Five-Year Follow-Up of Patients With Advanced Chronic Lymphocytic Leukemia Treated With Allogeneic Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning. Journal of Clinical Oncology. 26(30). 4912–4920. 182 indexed citations
17.
18.
Sorror, Mohamed L., Michael B. Maris, Rainer Storb, et al.. (2005). Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood. 106(8). 2912–2919. 1977 indexed citations breakdown →
19.
Diaconescu, Razvan, Marie-Térèse Little, Wendy M. Leisenring, et al.. (2005). What Role Is There for Antithymocyte Globulin in Allogeneic Nonmyeloablative Canine Hematopoietic Cell Transplantation?. Biology of Blood and Marrow Transplantation. 11(5). 335–344. 10 indexed citations
20.
Sorror, Mohamed L., Michael B. Maris, Rainer Storb, et al.. (2005). Hematopoietic cell transplantation (HCT)-specific-comorbidity index: A new tool for risk assessment before allogeneic HCT. Biology of Blood and Marrow Transplantation. 11(2). 23–24. 199 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael B. Maris Breakdown of academic impact, for papers by Myriam Labopin Breakdown of academic impact, for papers by Karen K. Ballen Breakdown of academic impact, for papers by Vincent T. Ho Breakdown of academic impact, for papers by Bipin N. Savani Breakdown of academic impact, for papers by Mauricette Michallet Breakdown of academic impact, for papers by Jean E. Sanders Breakdown of academic impact, for papers by Tapani Ruutu Breakdown of academic impact, for papers by Didier Blaise Breakdown of academic impact, for papers by Koen van Besien
Rankless by CCL
2026